METTL1 and head and neck squamous cell carcinoma: These results indicated that METTL1 markedly alters the tumor immune landscape and may be a promising target in HNSCC patients.269 METTL1 has also been found to increase mRNA translation efficacy through increased recognition of codons within the mRNA translation process.